Hercules BioVentures Partners

Hercules BioVentures Partners functions as a dedicated venture capital firm, specializing in providing equity investment capital to biotechnology companies. The firm focuses on identifying and supporting early and growth-stage enterprises that are actively engaged in drug discovery and development. Its investment strategy spans both the U.S. and Asian regions, aiming to cultivate a robust portfolio of life science innovations.

The firm was co-founded in 2014 by George J. Lee, Ph.D., who also serves as a general partner. Dr. Lee's extensive experience in venture management and the biotechnology sector underpinned the firm’s inception. The foundational insight behind Hercules BioVentures Partners was the strategic opportunity to build and nurture a strong biotech portfolio across key global markets.

Hercules BioVentures Partners caters to nascent and expanding biotechnology companies seeking crucial funding and strategic partnership. The firm’s long-term vision is to be a pivotal supporter of groundbreaking advancements in the life sciences. By investing in promising biopharmaceutical ventures, it aims to contribute significantly to the development of novel therapeutic solutions and address unmet medical needs worldwide.